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Abstract: Fifteen patients on maintenance
haemodialysis were studied before and after reuse of
cuprophane hollow-fiber dialysers to assess its
biocornpatibility and efficiency.
There was a significant increase in hernatocrite value
and hemoglobin level by the end of dialysis. Also,
there was a significant decrease in total leukcocytlc,
(neutrophilic & eosinophilic) and platelet counts with
a peak at IS minutes after the start of dialysis, then
there was a gradual increase till the end of dialysis
reaching near the predialysis value.
These changes occurred both in the first use and the
reuse sessions. The decrease in the neutrophilic count
with the reused dialyzer was significantly less
compaired to first use dialyzer.
The terminal complement complex (TCC)
significantly increased and reached its maximum after
IS minutes, then it began to decline till the end of the
dialysis. Similarly, these changes were significantly
less in the reuse dialyzers. No correlation was found
between the changes of the TCC and the decrease in
different cellular elements.
There was an increase in plasma bicarbonate and pH
by the end of dialysis. Also, hypoxia and hypocapnea
occured shortly after the start of dialysis session with
acetate dialysate, but they returned to their predialysis
values at the end of both dialysis sessions. This can
be attributed to the loss of carbon dioxide into the
dialysate with subsequent hypoventilation.
The clearances of urea, creatinine and phosphorus
showed insignificant difference between the new
and reused dialyzers at zero and 4hr time with
significant decrease by the end of dialysis in both
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dialysis session. This could be explained by keeping
the surface area of the reused dialyzers within the
acceptable values (80-100%) of the first use
dialyzer.
It can be concluded that reused dialyzers were to
some extent more hcrnocornpatiblc than the first use
dialyzers. Complement activation is not the sole
factor for the biocompatible reactions during
dialysis. Reuse of dialyzcrs can be a safe procedure
by adopteding appropriate sterilization, reprocessing
and storage techniques and limited number of reuse.
Introduction
Chronic haemodialysis IS one of the major
theraputic modalities for chronic renal failure
patients. Many factors determine the costs and it is
important to be reduced II j. The price of dialyzers
constitute the major part of dialysis costs. Reuse or
dialyzers was instituted in 1964 III.
Dialysis biocornpatibility, can be defined as the sum
of specific and non specific interactions between
blood and the artificial materials of the dialysis
circuit IZ].
During contact of blood with the dialysis
membranes, a variety of mediator are activated.
These may be soluble or cellular 131. The former
include peptides, fatty acids or amines. Among
these substances arc, complement components (Cl
fibrinogen, coagulation factors, prostaglandins,
thromboxane, leukotriens, kinins and histamine 131.
The cellular factors include, platelets which release
thromboxane, neutrophils which lead to release of
proteases and toxic oxygen radicals. While
monocyte and lymphocyte activation lead to
production of interleukln I and Iymphokines
respectively 131.Activation of the complement system
occurs by ei ther the classical or the alternati ve
pathway. The classical pathway is initiated with the
first component of complement (Cl) and the
alternative pathway is initiated with the third
complement componet (C3), with subsequent
activation and assembly of the terminal complement
components (C6, C7, C8) and multiples of C9 are
associated with C5b to form multi molecular
mernebrane attack complex (C5b-9) or the terminal
complement complex (TCC) 141.
The C5b-9 complex can react with plasmatic S-
protein, a scavenger which keeps the complex in fluid
phase. 141.
The aim of this work was to study the effect of reuse
of hollow fiber dialyzers on dialysis efficiency and
biocornpatibility.
Materials and methods
This study included 15 patients (8 males and 7
females) with end stage renal disease on maintenance
haemedialysis (HD) admitted to the Nephrology and
Dialysis Unit at Alexandria University Hospital. Their
ages ranged between 22-60 year with mean of 41+ 19
years and the duration of dialysis ranged between 32-
88 months with a mean 60±2S months.
We excluded patients with autoimune diseases,
intercurrent infection and those receiving immune-
supprcsivc therapy.
All patients were subjected to ruil history and
thorough clinical examination to define the symptoms
and signs or dialyzer reaction as headache, chest pain,
dyspnea, vomiting, angioneurotic oedema, rash and
muscle cramps.
Dialysis procedure
In the first usc session the dialyzer used was the
hollow fiber with cuprophane membrane and 1m2
surface area.
In the reuse session the dialyzer was reprocessed for
one reuse only using ECHO reuse system. Sodium
hypochlorite (5.25%) was used for cleaning and
dialox solution (peracetic acid 4.5%, acetic acid 6%,
and hydrogen peroxide 28%) as a disinfectant and
cleaner.
The dialysate was acetate dialysate composed of
sodium 134 mEq/ I. potassium 2 mEq/l, calcium 4
mEq/l, magnesium 1.5 mEq/l, chloride 105 mEq/l,
and acetate 36.6 mEq/l.
Dialysate flow rate was 500 ml/min, the flow of blood
pump was at 250 ml/min. The transmembrane
pressure (TMP) was adjusted at 100 mmHg and
venous pressure ranged from 50-80 mrnHg. Water
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used for dialysate was purified and treated by sand
filter, carbon filter, sofiner, reverse osmosis and
bacterial filter. The duration of this dialysis session
was four hours, three times weekly.
Collection of samples
All blood samples were collected at zero time before
dialysis, then at 15 minutes and 4 hours from the
start of dialysis. The samples were stored at -70 Oe.
Laboratory studies
I. The following tests were done for all blood
samples:
a) Hemoglobin (HB) and haernatoerit (Ht) [5].
b) Platelet count, total and differential leucocytic
count by electronic counter. Coulter T540+ [5].
c) Arterial blood gas analysis: partial arterial
oxygen and carbon dioxide pressure (Pa02,
PaC02), plasma bicarbonate (HC03) and pH
161.
2. The efficiency of the dialysers at the first use
and reuse sessions was esti mated twice; "at the
start and at the end of dialysis (4 hr). This was
achieved by measuring urea, creatinine and
phosphate clearances 16.7].
3. The biocornpatibility of the dialyzer was
measured by estimation of serum level of the
end product of complement activation C5b-9
complex using. Enzyme- Linked Inununosorbent
Assay (ELISA) technique. The kit was
purchased from QUIDEL, San Diego, USA [S].
This kit was used for the quantitification of
SC5b-9. It was a three-step procedure utilizing:
(I) a microassay plate coated with a mouse
monoclonal antibody which binds specifically to
SC5b-9, (2) Horse radish peroxidase (HRP)
conjugated antibodies to antigens of SC5b-9, and
(3) a chromogenic substrate IS].
Calculation of the results was done using the
standard currve: The absorbance was at 405
value for each SC5b-9 standard (y) and the
assigned nanograms of SC5b-9 per ml (ng/ml)
value for the standards A, Band C were used to
establish the standard curve. The best fit line was
drawn on the provided graphic paper. The ng/ml
concentration for each diluted sample then was
read on the X-axis for each corresponding
absorbance 405 value obtained.
Results
During the first use and the reuse sessions none of
the patients had any reaction.
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The surface area of the reused dialyzer ranged
between 80-100% with a mean of 96% from the intial
surface area of the first used dialyzer.
Hemoglobin and hemotacrit values increased
significantly during both first use and reuse
sessions, reaching its highest value at the end of
dialysis (table I).
Table 1. Mean percent change ±SD and statistical comparisons of hernatocrue (%), hemoglobin (g/dl), platelets (X 10' cell/mrri') and
terminal complement complex (SC5b-9ng/ml) in the first use and reuse at different periods of dialysis session.
Parameier 0-15 min (A) 0-4 hr. (C) F Vallie15 min·4 hr. (Bj
Haematocrite
First use 4.03±S.52 11.02±9.27 15.I±S.SI
Reuse 0.21±3.65 12.50±S.SO 12.60±7.72
Student "t" 1.621 0.451 0.S31
Paired "u" I.S32 4.602** 6.641 *'
Paired "t2" 0.223 5.503** 6.314**
Haemoglobin
First use 0.24±10.23 15.64±11.90 I5.68± 14.S2
Reuse -0.41 ±2.99 16.95±10.IS 16.33±S.80
Student "t" 0.244 0.321 0.152
Paired "ti' 0.091 5.092** 4.097*·
Paired "t2" 0.526 6.448** 7.193**
Plalelels
First use -16.76±12.15 22.50±20.26 -0.02±6.99
Reuse -6.65±403 I I.S2±9.43 4.22±7.7S
Student "t" 3.059' 1.854 1.573
Paired "t," 5.342** 4.30 I** 0.011
Paired "12" 6.395** 4.301** 2.108
Terminal compielmeni complex
First use 320.67±34278 -38.66±34.52 140.85±233.88
Reuse 118.53±9554 -23.9S±17.55 70.99±8I.7S
Student "t" 2.200* 1.468 1.092
Paired i'u" 3.612** 4.331 ** 2.334*
Paired "tz" 4.805** 5.291** 3.368**
5.97* (A.B) (A,C)
15.16** (A,B) (A,C)
7.66** (A,B) (A,C)
22.96** (A,B) (A,C)
28.78** (A,B) (A.C) (B.C)
23.73** (A,B) (A,C) (B.C)
8.38** (A,B)
14.70** (A, B) (B,C)
li = Paired t of the percent change at different periods in the firs: use session.
t2= Paired t of the percent change at different periods in the reuse session.
* = Significant P value at 5'k level. ** = Significant P value at lo/r level.
The total leucocytic, oesinophilic, neutrophilic and
platelet counts, blood gases (Pa02 and PaC02),
plasma bicarbonate and pH showed an early drop,
followed by rise to reache ncar thier predialysis
level by the end of the dialysis in both sessions
(table I, 2, 3).
Table 2, Mean percent change ±SD and statistical comparisons of total leuccocytic (x 10' cell/rum ') eosinophilic (ccll/i-nM3), neutrophilic
(x 103 ceil/nun ') and lymphocytic (x io' cell/rnrrr') COUnL; in the fir<.!usc and reuvc at different periods of dialysis sessions.
Parameter 0-15/11in (A) 15 lIIin-4 hr. (B) 0-4/ir. (C)
Total leukocytic COLI/II
First use -56.35±17.88 210.32± 186.90 IO.OO±32.26
Reuse -45.66±21.74 177.44±151.33 25.45±31.43
Student "t" 1.485 0.534 1.332
Paired "u" 12.201*· 4.351 ** 1.205
Paired "u" 8.114** 4.545** 3.137**
Eosinophilic eOU/11
First use -72.SS±27.44 160.99±182.99 3.34±45.19
Reuse -48.43±45.06 334.66±283.71 34.50±72.32
Student "t" 1.795 1.992 1.415
Paired "ti" 10.286** 3.407** 0.286
Paired ''t2'' 4.152** 4.56S** 1.847
F VlIl""
23.97** (A,B) (A,C) (B,C)
23.90** (A,B) (A,C) (l3.C)
17.65** (A,B) (A,C)
20.83** (A,B) (A,C)
Neutrophil COIIIlI
First use
Reuse
Student "1"
Paired "t,"
Paired "t,"
-76.32± I 1.62
-65.27± 16.05
2.159*
25.437**
15.750**
Lyniphocytic COl/ill
Fir,1 use
Reuse
Student "I"
Paired "I,"
Paired "tz
22. 15±94.0 I
-I 0.06±5 I .59
1.163
0.912
0.755
4+1.15±256.38
278.02± 156.37
2.142
6.709*'
6.886**
38.44± 74.14
103.78±149.05
1.520
2.008
2.696*
-0.17±23.53
19.82±29.+0
2.056
0.027
2.610*
27.27±56.33
26.24±38.71
0.058
1.87+
2.625*
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53.54** (A.B) cs.c:
56.24** (A.B) (A.C) (B.C)
0.18
5.77* (A.B) (B.C)
Abbreviations as table I.
Table 3. Mean percent change ± SD and statistical comparison of partial arterial oxygen and carbon dioxide pressures (Pa02, PaC02 mm
lig). plasma bicarbonate (HC03 I11Eq/L) and pH in patients on maintenance hemodialysis in the first use and reuse at different periods of
dialysis sessions.
Parameter 0-15mill(A) F Value15 lIIill-4 hr. (BJ 0--1 hr. (C)
FirSI usc -17.71±9.39
-15.82±8.22
0.596
7.301**
7.458**
Reuse
Student "I"
Paired "I,"
Paired "I,"
PaCoz
Firsl usc
Reuse
Student "t"
Paired "I,"
Paired "I,"
-28.91 ± 19.57
-13.43± 13.55
2.521 *
5.721 **
3.834**
Plasma /ICO,
Firsl usc
Reuse
Student "t"
Paired "I,"
Paired "11"
-6.88± 11.28
-2.28±5.71
1.444
2.362*
1.541
P/I
Firsl use
Reuse
Studcru "I"
Paired "I,"
Paired "I,"
-O.12±0.67
-0.29±0.75
0.676
0.678
1.491
17.02±IO.14 -4.15±9.84
20.88±17.38 1.00±12.16
0.741 1.281
6.494** 1.635
4.656** 0.311
47.85±+5.62 -2.15±15.62
31.71±24.31 12.28± 18.66
1.2+3 2.315*
4.063** 0.532
5.056** 2.545*
36.78±21.45 25.77±14.12
31.58±14.14 28.33±14.03
0.781 0.525
6.465*- 7.061**
8.561 ** 7.842**
2.04±O.273 1.92±0.95
2.19±O.61 1.89±O.82
0.621 0.080
10.711 ** 7.792**
13.832** 8.914**
47.89** (A.B) (A,C) (B,C)
29.33** (A,B) (A,C) (B,C)
25.22** (A,B) (A.C) (B.C)
20.54** (A.B) (A,C) (B,C)
29.49** (A.B) (A,C)
36.68** (A.B) (A,C)
34.71 ** (A,B) (A,C)
50.93** (A,B) (A,C)
Abbreviations as table I.
There was a significant increase in the Tee (SeSb-9)
level at IS minutes then it declined till the end of
dialysis, although it remained higher than the
predialysis level. This occured both at the first use
and reuse sessions (table I).
The decrease in the neutrophil and platelet counts and
the increase in SSb-9 level were significantly less in
the reuse session than the first usc session (table 1,2).
Urea, creatinine and phosphorus clearance decreased
significantly by the end of dialysis (4 hrs), This
decrease was insignificantly different comparing the
first use and reused dialyzers (table 4).
There was a significant positive correlation between
the % changes of the surface area after reuse and
urea and creatinine clearance at zero time (r = 0.686,
0.700 respectively) and at4 hr time with creatinine
clearance only (r = O. 5 84).
No correlation was found between the % change of
Tee (Sc5b-9) and the neutrophilic count at both the
first use and the reuse session at 0-15 min and 15
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min - 4 hr times. (r = -0.232, 0.100, -0.331, -0.054 respectively).
Table 4. Mean ±SD and statistical comparisons of urea. creatinine and phosphorous clearances (nil/min) at the beginning and the end or the
first use and reuse sessions.
Parameter Omin Paired ..t "4 hr. o /IIill·-I hr. 'Tc change
128.89± 16.32 I07.53± 18.22 -15.86± 13.56
I 15.53± 12.23 96.00± 1661 -16.73±11.91
2.512* 1.810 0.191
134.13±19.25 119.80±14.16 -10.03±8.39
I24.80± 16.60 II 1.27± 19.24 -10.89±9.26
1.425 1.385 0.271
114.78±25.32 103.80±14.86 -6.54±17.92
I~.20±20.46 95.13±J2.15 -8.08±31.87
1.261 0.951 0.165
Urea Clearance
First use
Reuse
Student "t"
Creatinine clearance
First lise
Reuse
Student "t"
Phosphorous clearance
First use
Reuse
Student "I"
4.531 **
5.442**
4.622**
4.552**
1.41 I
0.987
Abbreviations as table I.
Discussion
This study showed that the TCC arC (SC5b-9) as one
of the parameters of biocompatibility was
significantly increased early in both dialysis session
which was less in the reuse than the first use session
denoting that reused dialyzers were more
biocompatible, although still activate the complement
cascade to a certain extent.
These results agree with the results of Deppisch et al
[8] who first describe the use of TCC as sensitive
index of bioincompatibility In haemodialyzed
patients.
The other complement (C) components specially C3a
and C5a were also found by many authors to be
increased during dialysis using unsubstituted cellulose
dialyzers than the synthetic modified cellulose or in
the reused dialyzers [9-l2J.
The increase in complement components during
dialysis reflect the balance between its activation and
clearance. Also, the subsequent decline could be
related to deposition of C fragements on the activating
sites of the dialyzer membrane surface or loss in the
dialysate [9-l2J.
Both the SC5b-9 and peripheral leukocyte are not
expected to penetrate the dialyzer membrane, so
measurement of TCC may be an index of
biocompatibility, complementary to and independent
of the C-anaphylatoxins [8].
The complement system stimulates nucleated cells
with the release of different cytokines [3,13].
Dialysis associated leukopenia and thrombocytopenia
were studied as parameters of bioincompatibility.
Both occurred in the first use and the reuse sessions
but was less with the reused dialyzer than with the
first use dialyzer, this also denote that reused
dialyzers are more biocornpatible than the new one.
Hemodialysis induced neutropenia was also
observed and reported by many authors 113-181.
Neutropenia is associated with increased expression
of cell surface adhesion molecules that was
supposed to be stimulated by complement activation
1191.
Himmelfarb ct al, 1191 concluded that MAC-l
expression induce changes in granulocyte cell
surface with subsequent the development of
granulocytopenia with their adherence to the
dialysis membrane and sequestration In the
pulmonary capillaries, but it is not sufficient to
rnainturn it.
The subsequent reversal of the neutropenia was
secondary to the decrease in the CAM-l expression
with down regulation of another adhesion receptors
of the selectin family (LAM-I) with their shedding
from their attaching surface receptors to return back
to the circulation.
The absence of correlation between TCC changes
and changes in blood count, may suggest that
complement was not the sole mediator of
neutropenia and changes in other cellular factors.
Other factors such as cytokines, chemotactic factors
and Iipopoly-saccharides may be important 120,211.
Studies done on the effect of reprocessing to
improve dialysis induced neutropenia yielded
controversial results and this can be explained by
the di fferent reuse methods and the type of
membranes studied 19,10,12,181.
The beneficial effect of reuse had been attributed to
the protective coating of the surface of dialyzer
membrane during its first usc, particularly the
fixation of C3b on cuprophane. which could block
complement activating sites [9,121.
Heparin induced thrombocytopenia (MT) had been
reported in 5% of (22) patients with endothelial cell
injury.
The increase in Hb and Ht values by the end of
dialysis could be attributed to the relative
hemoconcentration due to ultrafiltration. This was
supported by the finding of negative correlation at end
of dialysis between changes of atrial natiuretic peptide
(ANTI) and blood volume and Ht [231.
The occurrence of hypoxemia and hypocapnea early
in dialysis was the subject of many investigatious,
114,24,251·
Hypoxemia and the early decrease of plasma HC03
and pH were attributed to many factors including
alveolar hypoventilation following carbon dioxide
losses into the dialysate (C02 unloading).
intrapulmonary leukosiasis, changes in the respiratory
quoteint during acetate metabolism and direct effect
of acetate on the central respiratory center. The
subsequent rise of these parameters was related to the
correction of acidosis by acetate buffer in the
dialysate 124,251.
The efficiency of the reused did not differ from that of
the first use dialyzer and the decrease of efficiency
by the end of dialysis was the same in both dialysis
sessions. This could be explained by keeping the
surface area of the reused dialyzer which was within
the acceptable value (80-1000/£·)of surface area of the
first use dialyzer 1261.
In this study none of the patients had symptoms or
signs of dialyzer reactions neither in the first use nor
in the reuse sessions. This could be partly attributed to
proper rinse of the fresh hollow fiber dialyzer with
saline before dialysis. This process could wash out
any traces of the stcraliscr used which was the
ethylene dioxide (ETO). It was claimed that it can
cause type I hypersensitivity reaction and anaphylaxis
127-291.
Controversial results were shown by different studies
due to the usc of different icchiniqucs of sterilization
and lor cleaning of the dialysers during reuse process
110.28-311.
Septicemia and endotoxemia had been also reported
with reused dialysis 11.11.211.
Underdialysis had been reponed with the reuse
dialyzer. but could be due to many causes including
improper technique of rcsuc, errors in selling blood
flow. blood access recirculation and short dialysis
duration 132,331.
We can conclude that following appropriate
procedures. implementation of quality assurance
systems and close monitoring of all procedures,
dialyscr reuse is safe, ensures effective therapy and
provides economic benefit.
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